| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |